Efficacy evaluation of PC-VIPR for the hemodynamic assessment of intestinal tract by using daikenchuto (TU-100)

Efficacy evaluation of PC-VIPR for the hemodynamic assessment of intestinal tract by using daikenchuto (TU-100) - Efficacy evaluation of PC-VIPR for the hemodynamic assessment of intestinal tract by using daikenchuto (TU-100)

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000027472

Enrollment

Registered

2017-05-24

Start date

2017-05-24

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteers

Interventions

State of taking daikenchuto(TU-100)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Healthy adults over 20 years old 2.Systolic blood pressure under 140mmHg 3.Written informed consent

Exclusion criteria

Exclusion criteria: 1. Person with MRI contraindications (claustrophobic, metal in the body, etc.) 2.High blood pressure 3.The past of the heart disease 4.With the history of abdominal surgery 5.Under the medical treatment 6.Disable to keep face up position 7.Pregnant or possibly pregnant 8.Under the nursing

Design outcomes

Primary

Measure	Time frame
Ratio of SMA flow volume at t=25 min to t=-25 min measured by US and PC-VIPR.	—

Countries

Japan

Contacts

Public ContactMayu Sakata

Hamamatsu University School of Medicine Surgery 2, Divisions of Gastroenterological & Vascular Surgery

mayu-s@hama-med.ac.jp053-435-2279

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026